Ye Dong

Shanxi Medical University

Papers

1

Total Citations

75

H-Index

1

About

Dr. Ye Dong is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex hepatopancreatobiliary procedures, particularly robotic pancreatic surgery. His most impactful work, a 2021 multicenter study comparing robotic versus open pancreaticoduodenectomy in low-risk surgical candidates, has garnered 75 citations and provides critical evidence for the safety and oncological efficacy of the robotic approach. This landmark investigation addressed the limitations of prior single-center studies by demonstrating comparable perioperative and oncological outcomes, helping to establish robotic pancreaticoduodenectomy as a viable alternative in carefully selected patients. Dr. Dong’s contributions are shaping modern surgical practice by rigorously evaluating how technology can reduce recovery times without compromising cancer clearance. His research is essential reading for surgeons and trainees navigating the transition toward robotic-assisted oncology, offering data-driven insights that balance innovation with patient safety. Through his work, Dr. Dong continues to influence the evolution of pancreatic cancer surgery, bridging the gap between technical feasibility and clinical evidence.

Research Focus

Key Achievements

1
H-Index
1
Papers
75
Total Citations
75
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates
75 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Shanxi Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago